Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Express Scripts
AstraZeneca
Dow
Johnson and Johnson

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

ENOXAPARIN SODIUM (PRESERVATIVE FREE) Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Enoxaparin Sodium (preservative Free) patents expire, and when can generic versions of Enoxaparin Sodium (preservative Free) launch?

Enoxaparin Sodium (preservative Free) is a drug marketed by Amphastar Pharm, Apotex Inc, Sandoz, and Teva. and is included in four NDAs.

The generic ingredient in ENOXAPARIN SODIUM (PRESERVATIVE FREE) is enoxaparin sodium. There are thirteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the enoxaparin sodium profile page.

Summary for ENOXAPARIN SODIUM (PRESERVATIVE FREE)
Drug patent expirations by year for ENOXAPARIN SODIUM (PRESERVATIVE FREE)
Pharmacology for ENOXAPARIN SODIUM (PRESERVATIVE FREE)

US Patents and Regulatory Information for ENOXAPARIN SODIUM (PRESERVATIVE FREE)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 076726-007 Jun 23, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
Amphastar Pharm ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 076684-001 Sep 19, 2011 AP RX No No   Start Trial   Start Trial   Start Trial
Sandoz ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 077857-005 Jul 23, 2010 AP RX No No   Start Trial   Start Trial   Start Trial
Teva ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 076726-003 Jun 23, 2014 AP RX No No   Start Trial   Start Trial   Start Trial
Amphastar Pharm ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 076684-007 Sep 19, 2011 AP RX No No   Start Trial   Start Trial   Start Trial
Amphastar Pharm ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 076684-004 Sep 19, 2011 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Colorcon
AstraZeneca
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.